JUDY C. LEWENT

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Motorola Solutions, Inc.

Filing Date Source Excerpt
2016-03-28 Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive. 2015 total compensation for Ms. Lewent was $260,019.
2017-03-27 Ms. Lewent served as CFO of Merck. Board Committees: Audit (Chair), Executive. 2016 director compensation total $260,031.
2018-03-28 Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. 2017 director compensation total $312,583.
2019-03-28 Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive Director Qualifications: Independent Age: 70 Director since: 2011
2020-03-27 Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Fees Earned or Paid in Cash: 125,000, Stock Awards: 190,066, Total: 315,066
2021-04-01 Ms. Lewent served as CFO of Merck. Board Committees: Audit (Chair), Executive. 2020 compensation total $301,271.
2022-03-31 Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Total compensation: $315,184.
2023-03-30 Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Compensation: $345,162
2024-03-28 Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive Director Qualifications: Public company CFO, financial and accounting expertise, capital allocation, global business, and human capital management experience as the former CFO of Merck Principal Occupation: Retired; Formerly Executive Vice President & Chief Financial Officer, Merck & Co., Inc. Age: 75 Race: White Director since: 2011 Independent

THERMO FISHER SCIENTIFIC INC.

Filing Date Source Excerpt
2018-04-10 Ms. Lewent, age 69, has been a director of the Company since May 2008. She was Chief Financial Officer of Merck & Co., Inc.
2019-04-09 Former Chief Financial Officer, Merck & Co., Inc.
2020-04-07 Ms. Lewent’s nearly 20 years in executive management roles at Merck & Co., Inc. enables her to bring valuable experience in a highly regulated industry.

Data sourced from SEC filings. Last updated: 2025-07-01